Summary

MindWalk has launched a groundbreaking B Cell Llama platform designed to facilitate Nanobody discovery within the new Bispecific and Cell Therapy era. The application leverages HYFT technology to detect functional adjacency linked to portfolio risk in sophisticated AI-constructed therapeutics, significantly enhancing precision. The system is validated through a breakthrough targeting pathogenic TDP-43 protein in neurodegenerative disease scenarios. Users can now build their own drug discovery platforms with partners.

The solution integrates advanced lab research capabilities to streamline the entire therapeutic discovery workflow. It covers a comprehensive range of critical areas including protein production, partnership readiness, and the Vault, ensuring a seamless ecosystem for the next generation of medical advancements. Through strategic asset partnerships, this innovative approach allows organizations to rapidly scale and deliver impactful solutions for complex genetic diseases.

Title

All in one biointelligence ecosystem by MindWalk

Description

MindWalk integrates AI, data, and lab intelligence into a unified biointelligence ecosystem, accelerating biologics discovery from target to clinic.

Keywords

discovery, more, overview, read, technology, data, drug, research, platform, build, therapeutics, partnership, ready, brand, antibody, resource, blog

NS Lookup

A 199.60.103.145, A 199.60.103.45

Dates

Created 2026-03-09

Updated 2026-03-30

Summarized 2026-03-31